Abstract The role of the insertion/deletion polymorph-pathy [1] [2] [3] [4] [5] and renal disease in general [6][7][8][9] has remained controversial. It has been proposed that ism of the angiotensin-converting enzyme (ACE ) gene in the genesis of diabetic nephropathy has been contro-patients with type I diabetes who are homozygous for the I allele are less likely to develop nephropathy [1 ], versial. It has recently been proposed that progression occurs more rapidly in individuals with diabetic and but this has not been uniformly confirmed [2, 3] 
presumed nephropathy as assessed by albuminuria did diabetes clinics, one Polish diabetes clinic and four German not differ with respect to DD genotype. In conclusion, dialysis centres. Diabetic nephropathy was defined by the in this study, which was limited by sample size, patients minimum criterion of albumin excretion Á30 mg/24 h. As with the highest renal risk more frequently had the controls we examined 256 healthy blood donors from the DD genotype. This would be compatible with a greater Heidelberg region. risk of (or rate of ) progression to end-stage renal
The ACE gene polymorphism was determined using PCR failure.
amplification as described previously [ 3] . To avoid preferential amplification of the D allele we added 5% DMSO to the reaction mix [10 ] . The alleles were separated on agarose gels.
Introduction
The role of the angiotensin-converting enzyme (ACE ) Results gene polymorphism in development of diabetic nephro- nephropathy, differed from patients on dialysis both group with a high proportion of non-diabetic renal disease. Undoubtedly, however, renal morphology is with respect to genotype distribution and allele frequencies, i.e. a higher proportion of patients with more heterogeneous in type II than in type I diabetes dialysis were homozygous for the D allele and the [14, 15] . It is not known whether albuminuric patient frequency of the D allele was significantly higher. with type II diabetes and non-specific lesions carry the Genotype distribution of all groups, except the group same renal risk as microalbuminuric patients with type of patients with nephropathy (n=311), were in I diabetes. Hardy-Weinberg equilibrium.
A striking observation, however, was the fact that patients with type II diabetes on dialysis had a large excess of the D allele. The strength of this observation Discussion is limited: (i) by the small sample size; (ii) by the fact that it is the result of subsample testing; and (iii) by the fact that longitudinal data are not available. The negative findings in the comparison between albuNevertheless the magnitude of the difference is so minuric and non-albuminuric patients with type II striking as to warrant preliminary reporting. diabetes are in line with previous observations sugSeveral explanations as to the pathomechanisms gesting that in patients with type II diabetes the risk involved are conceivable. It has been proposed that of developing significant albuminuria is not related to individuals who are homozygous for the D allele polymorphism in the ACE gene [3] . The strength of progress more rapidly to end-stage renal failure; this this conclusion may be limited by several considerawas reported in non-diabetic renal disease [7, 8] , as tions. It has been suggested that in type II diabetes well as in diabetic renal disease [4, 5] . The observation albuminuria is not a specific indicator of nephropathy of accumulation of the DD genotype in the cohort of [11 ] . More recent autopsy [12] and biopsy studies [13, 14] argue against contamination of this patient dialysed patients would be consistent with the notion 
